In conclusion, the results obtained show that variants in genes related to oxidative stress influence the clinical characteristics of CML patients, namely the development and degree of TKI resistance, mutations in the BCR::ABL1 gene, the evolution of the disease, and the overall survival of CML patients. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.